Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)

NCT05241860 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Castration-Sensitive Prostate Carcinoma
Metastatic Prostate Carcinoma
Stage IV Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Stage IVB Prostate Cancer AJCC v8

Interventions

OTHER: Pharmacotherapy Discontinuation
OTHER: Follow-Up
OTHER: Questionnaire Administration
OTHER: Quality-of-Life Assessment

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]